Atomo NewsGet the app

Ozempic

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012.Semaglutide is a GLP-1 receptor agonist, meaning that it mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control.

Read more in the app

Weight loss drug Ozempic could protect the brain from stroke

Ozempic really could turn back the clock on your biological age

Weight Comes Back When You Stop Taking Drugs Like Ozempic, Study Finds

An injected gel could make drugs like Ozempic last longer

You don't need to take drugs like Ozempic consistently to lose weight

International Conference on Nutrition in Medicine tackles trending health topics from ultra-processed foods to Ozempic in Washington, DC, Aug. 14-16 - EurekAlert!

Beyond Ozempic: New weight loss drug rivals surgery

Ozempic Without Nausea: Brain Cell Discovery Could Change Weight-Loss Drugs

Weight-Loss Drugs Like Ozempic Can Leave Lasting Damage in Your Mouth

Landmark Study Shows Ozempic May Treat This Deadly Liver Disease

Expert Reveals a Drug-Free Way to Mimic The Effects of Ozempic

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

People on Ozempic start disliking meat and fried foods. We're starting to learn why.

Ozempic and Wegovy ingredient may reverse signs of liver disease

Why Ozempic and Wegovy Might Change Your Favorite Food

Daily pill could replace weight-loss shots like Ozempic and Wegovy

Popular Weight Loss Drugs Like Ozempic May Trigger Depression, Doctors Warn

Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar

Weight-Loss Drugs Like Ozempic May Guard Against Dementia, Research Finds

Drugs like Ozempic and Wegovy could significantly cut dementia risk

« Expanse:
Quantum Worlds »